1.Expression of Neuropeptides and Their Receptors in Melasma.
Hyun Ju LEE ; Hana BAK ; Sung Eun CHANG ; Jee Ho CHOI ; Myeung Nam KIM ; Beom Joon KIM
Korean Journal of Dermatology 2008;46(5):627-632
BACKGROUND: The pathogenesis of melasma has not yet been clearly demonstrated. But, clinical manifestations such as remarkable lesional symmetry and the distribution related to trigeminal nerves, suggest that the neural system could play a pathogenic role in melasma. OBJECTIVE: This study was carried out to examine the expression of some neuropeptides and their receptors, which are well known to be major contributors of neuroinflammation in many dermatoses, in melasma lesions. METHODS: Skin biopsies were obtained from the lesional and non-lesional facial skin of 6 Korean women with melasma. Immunofluorecence staining and confocal laser scanning microscopy were performed. RESULTS: In our results, no difference could be detected with regard to the intensity of immunoreactivity for vasoactive intestinal peptide (VIP), calcitonin gene-related peptide (CGRP), calcitonin gene-related peptide receptor (CGRPR), substance P (SP), substance P receptor (SPR), somatostatin (SOM), pituitary adenylate cyclase activating peptide (PACAP) and pituitary adenylate cyclase activating peptide receptor (PACAPR) in the lesional skins compared with the non-lesional skins. CONCLUSION: These results suggest that neuroinflammation induced by neuropeptides such as substance P, calcitonin gene-related peptide, vasoactive intestinal peptide, and somatostatin and their receptors included in this study, are not directly associated with melasma pathogenesis.
Adenylyl Cyclases
;
Biopsy
;
Calcitonin Gene-Related Peptide
;
Female
;
Humans
;
Melanosis
;
Microscopy, Confocal
;
Neuropeptides
;
Receptors, Neurokinin-1
;
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
;
Skin
;
Skin Diseases
;
Somatostatin
;
Substance P
;
Trigeminal Nerve
;
Vasoactive Intestinal Peptide
2.The factors influencing the continuity of patient care in family practice.
Hyun Joo JUNG ; Ga Young LEE ; Tae Jin PARK ; Byung Sung KIM ; Eun Jung HAN ; Jin Ju BAK ; Kwang Sug BAE
Journal of the Korean Academy of Family Medicine 1997;18(7):731-738
BACKGROUND: Continuity is very important in primary care, and in most studies continuous care has been reported to have a good effect on the result of care. So we studied the factors influencing the continuity of patient care by physician in charge, especially in case of out-patient department in a university hospital. METHODS: We posed questionnaires to 55 persons who had visited continually to Paik Hospital in Pusan for at least 6 months. We classified them into three groups according to the degree of continuity using 'Modified Continuity Index', and compared the lower group (18 patients) with the higher group(18 patients). RESULTS: The incame of the higher continuity group was significantly less than that of the lower continuity group(P=0.042). But there were no significant differences between the two groups according to sex, age, the type of family, marital status, job and the level of education. The higher continuity group agreed more significantly than the lower continuity group with the question whether it is important to be treated continually from physician in charge(P=0.005). About the reasons for visiting to other doctors instead of the physician in charge, most of them in both group replied that they could not keep appointment. And there were no significant differences in the care pattern of disease between the groups. CONCLUSIONS: To improve the continuity of patient care by physician in charge, it is necessary to instruct the importance of continuous care to the patients and to motivate them through various methods.
Busan
;
Continuity of Patient Care*
;
Education
;
Family Practice*
;
Humans
;
Marital Status
;
Outpatients
;
Primary Health Care
;
Surveys and Questionnaires
3.New Melasma Treatment by Collimated Low Fluence Q-switched Nd : YAG Laser.
Se Yeong JEONG ; Sung Eun CHANG ; Hana BAK ; Jee Ho CHOI ; Il Hwan KIM
Korean Journal of Dermatology 2008;46(9):1163-1170
BACKGROUND: Laser treatment in melasma has previously failed because of the resulting inflammation and consequent pigmentation and excessive thermal damage caused by the use of high fluence. OBJECTIVE: This study is aimed at establishing the concept of the collimated low fluence Q-switched Nd : YAG laser as a treatment for melasma by investigating its therapeutic effects clinically as well as histopathologically. METHODS: 27 patients were treated weekly with Q-switched Nd : YAG laser (1,064 nm wavelength, 7 mm spot size, 1.6~2.5 J/cm2 fluence) for 8 weeks. The results were evaluated based on standardized clinical images that used Robo skin analyzer, spectrophotometer, MASI score and general severity. RESULTS: 17 (58.8%) patients showed "GOOD" (50~75% improvement) and no case of full recurrence was examined and partial recurrence was detected in 12/17 patients. Common adverse effects include pain, erythema, and temporary edema. Rarely partial hypopigmented macules and diffuse hyperpigmentation appeared. Additional studies, such as immunohistochemical examination and electron microscopic examination, are also currently in progress. CONCLUSION: The collimated low fluence Q-switched Nd : YAG Laser is effective in melasma treatment. This treatment method is a new concept that can be described as selective photothermolysis with minimal thermal damage and inflammation reaction to affected tissues by pigmentation. We consider this treatment method should be regarded as Minimized Selective Photothermolysis (MSP) that will provide a new effective treatment for melasma.
Edema
;
Electrons
;
Erythema
;
Humans
;
Hyperpigmentation
;
Inflammation
;
Lasers, Solid-State
;
Melanosis
;
Pigmentation
;
Recurrence
;
Skin
4.Laparoendoscopic Single Site Surgery for the Treatment of Huge Ovarian Cysts Using an Angiocatheter Needle
Eun Young KI ; Eun Kyung PARK ; In Cheol JEONG ; Sung Eun BAK ; Hye Sung HWANG ; Yoo Hyun CHUNG ; Min Jong SONG
Yonsei Medical Journal 2019;60(9):864-869
PURPOSE: The aim of this study was to evaluate the feasibility and safety of laparoendoscopic single site (LESS) surgery using an angiocatheter needle in patients with huge ovarian cysts (diameter ≥15 cm). MATERIALS AND METHODS: Thirty-one patients with huge ovarian cysts underwent LESS surgery using an angiocatheter needle between March 2011 and August 2016. An intra-umbilical vertical incision (1.5–2.0 cm) was made in the midline. After the cyst wall was punctured using an angiocatheter needle, the fluid contents were aspirated with a connected vacuum aspirator. After placing a Glove port in the umbilical incision, LESS surgery was performed using a rigid 0-degree, 5-mm laparoscope and conventional, rigid, straight laparoscopic instruments. Knife-in-bag morcellation was instituted for specimen collection. RESULTS: The median maximal diameter of ovarian cysts was 18 cm (range, 15–30 cm), the median operation time was 150 minutes (range, 80–520 minutes), and the median volume of blood loss was 100 mL (range, 20–800 mL). Three patients (9.7%) were diagnosed with malignant ovarian cancer using intraoperative frozen examination, and 1 patient was converted to laparotomy due to advanced disease. Thirty patients underwent LESS, and there was no need for an additional laparoscopic port. CONCLUSION: LESS surgery using an angiocatheter needle, with leaving only a small postoperative scar, was deemed feasible for the management of huge ovarian cysts.
Cicatrix
;
Female
;
Humans
;
Laparoscopes
;
Laparotomy
;
Morcellation
;
Needles
;
Ovarian Cysts
;
Ovarian Neoplasms
;
Specimen Handling
;
Vacuum
5.Proteome Analysis of Differential Protein Expression in Cervical Cancer Cells after Paclitaxel Treatment.
Eun Kyoung YIM ; Jun Sang BAE ; Seung Bak LEE ; Keun Ho LEE ; Chan Joo KIM ; Sung Eun NAMKOONG ; Soo Jong UM ; Jong Sup PARK
Cancer Research and Treatment 2004;36(6):395-399
PURPOSE: It is well known that infection with HPV (human papillomavirus) is the main cause of cervical cancer and certain types of HPV are recognized as carcinogens. At present, there is little information regarding the antineoplastic mechanism of paclitaxel against cervical carcinoma cells. We thus tried to analyze differential protein expression and antineoplastic mechanism-related proteins after paclitaxel treatment on cervical cancer cells by using a proteomic analysis and to investigate the mechanism of action. MATERIALS AND METHODS: Using proteomics analysis including 2-DE and MALDI-TOF-MS, we detected the antineoplastic mechanism-related proteins. Then, we performed western blot analysis for apoptosis- and transformation- related proteins to confirm expression patterns derived from proteome analysis after paclitaxel treatment. RESULTS: We identified several cellular proteins that are responsive to paclitaxel treatment in HeLa cells using proteomics methods. Paclitaxel treatment elevated main-ly apoptosis, immune response and cell cycle check point- related proteins. On the other hand, paclitaxel treatment diminished growth factor/oncogene-related proteins and transcription regulation-related proteins. Also, in the HPV-associated cervical carcinoma cells, paclitaxel demonstrated anti-proliferative activity through the membrane death receptor-mediated apoptotic pathway and the mitochondrial-mediated pathway. CONCLUSION: Identification and characterization of functionally modulated proteins involved in anti-cancer regulatory events should lead to a better nderstanding of the long-term actions of paclitaxel at the molecular level and will contribute to the future development of novel therapeutic drug treatments based upon current therapies.
Apoptosis
;
Blotting, Western
;
Carcinogens
;
Cell Cycle
;
Hand
;
HeLa Cells
;
Humans
;
Membranes
;
Paclitaxel*
;
Proteome*
;
Proteomics
;
Uterine Cervical Neoplasms*
6.Prevalence of Pancreatic Cancer in Diabetics and Clinical Characteristics of Diabetes-associated with Pancreatic Cancer: Comparison between Diabetes with and without Pancreatic Cancer.
Seung Goun HONG ; Jae Seon KIM ; Sung Joo JUNG ; Moon Kyung JOO ; Beom Jae LEE ; Jong Eun YEON ; Jong Jae PARK ; Kwan Soo BYUN ; Young Tae BAK
The Korean Journal of Gastroenterology 2009;54(3):167-173
BACKGROUND/AIMS: In Korea, the prevalence of pancreatic cancer (PC) in general population has been reported as 7 in 100,000. However, that in diabetes mellitus (DM) has not been elucidated yet. This study was designed to estimate the prevalence of PC among DM patients, and characterize and compare the patients with DM with and without PC. METHODS: 5,082 patients (4,890 DM without PC, 78 PC with DM, and 114 PC without DM) were enrolled from Korea University Guro Hospital during a period of 4 years between January 2004 and January 2008. RESULTS: The prevalence of PC in DM patients was 1.6% and that of DM in PC patients was 40.6%. No significant differences in the clinical characteristics except HbAIc and ALP were observed between PC patients with DM and without DM. Among 78 PC patients with DM, DM was diagnosed in 19 (29.4%) and 29 (37.1%) patients concomitantly or within 2 years prior to the diagnosis of PC, respectively. Among the cases with recent onset DM (less than 2 years' duration), the disease duration of DM before the diagnosis of PC was less than 1 year in 14 patients (17.9%) and 1 to 2 years in 15 patients (19.2%). DM patients with PC were found to have significantly higher ALT, total bilirubin, and ALP levels than in DM patients without PC. CONCLUSIONS: The prevalence of PC in DM patients was 1.6% and was higher than in the general population. Recent onset DM was frequent in PC patients (less than 2 years' duration). We recommend close follow-up for at least 2 years in new-onset diabetes.
Aged
;
Alanine Transaminase/blood
;
Alkaline Phosphatase/blood
;
Bilirubin/blood
;
Diabetes Complications/diagnosis/*epidemiology
;
Diabetes Mellitus/diagnosis/*epidemiology
;
Female
;
Hemoglobin A, Glycosylated/analysis
;
Humans
;
Male
;
Middle Aged
;
Pancreatic Neoplasms/complications/diagnosis/*epidemiology
;
Prevalence
;
Time Factors
7.Psoriasis Aggravated by Adalimumab: A Paradoxical Adverse Reaction.
Ounjae PARK ; Seung Gyun IN ; Seong Min KANG ; Seung Phil HONG ; Hana BAK ; Chong Hyun WON ; Sung Eun CHANG ; Mi Woo LEE ; Jee Ho CHOI ; Kee Chan MOON
Korean Journal of Dermatology 2010;48(6):513-516
Adalimumab, a recombinant human IgG monoclonal antibody, selectively blocks tumor necrosis factor-alpha (TNF-alpha) and has been successfully used in the treatment of immune-mediated diseases. In particular, its efficacy has been proven in the treatment of rheumatoid arthritis, spondylarthritis, lymphoproliferative diseases and inflammatory bowel disease. Its use has also been studied for the treatment of psoriasis and yet, paradoxically, cases of new onset or exacerbation of psoriasis continue to increase in patients undergoing treatment with anti TNF-alpha agents. A 51-year-old woman had arthritis for a year and was diagnosed with psoriatic arthritis. After she had received adalimumab for psoriatic arthritis five times during one year, erythematous eruptions were found on her entire body. She then stopped adalimumab therapy for two months, although her skin lesions did not resolve. The patient was diagnosed with psoriasis through biopsy and began using cyclosporine, a topical steroid used for treatment of psoriasis.
Antibodies, Monoclonal, Humanized
;
Arthritis
;
Arthritis, Psoriatic
;
Arthritis, Rheumatoid
;
Biopsy
;
Cyclosporine
;
Female
;
Humans
;
Immunoglobulin G
;
Inflammatory Bowel Diseases
;
Middle Aged
;
Psoriasis
;
Skin
;
Spondylarthritis
;
Tumor Necrosis Factor-alpha
;
Adalimumab
8.A case of insulin autoimmune syndrome.
Hyun CHO ; Ssang Yong OH ; You Jung KIM ; Chan Sung BAK ; Eun Sook KIM ; Young Il KIM ; Il Seong NAM-GOONG
Korean Journal of Medicine 2009;76(Suppl 1):S122-S126
Insulin autoimmune syndrome is an uncommon cause of hypoglycemia. According to the type of antibody, it can be classified as caused by insulin or insulin receptor autoantibodies. Generally, insulin autoimmune syndrome develops following exposure to exogenous insulin or sulfhydryl medications, although insulin or insulin receptor antibody may also occur spontaneously. We treated a 54-year-old woman who developed spontaneous hypoglycemia. The patient had repeated hypoglycemia despite the infusion of dextrose solution. Her serum insulin, c-peptide, and insulin autoantibody were elevated, even during the hypoglycemic periods. Insulin receptor autoantibody and HLA-cw4/B62/DR4 were positive. After steroid and diazoxide treatment, the hypoglycemic symptoms improved gradually. No further hypoglycemic episodes occurred after tapering the medication over 1 year. We present a case of insulin autoimmune syndrome with positive insulin and insulin receptor autoantibodies.
Autoantibodies
;
C-Peptide
;
Diazoxide
;
Female
;
Glucose
;
Humans
;
Hypoglycemia
;
Insulin
;
Middle Aged
;
Receptor, Insulin
9.A Case of Tuberculous Lymphadenitis Causing Obstructive Jaundice.
Chang Hong LEE ; Jae Seon KIM ; Goo LEE ; Young Tae BAK ; Jin Ho KIM ; Jong Guk KIM ; Nam Hee WON ; Eun Rae JO ; Sung Joon LEE ; Hong Young MOON
Korean Journal of Gastrointestinal Endoscopy 1994;14(1):115-120
Obstructive disorders of the biliary trees include occlusions of the bile duct lumen by stones, intrinsic disorders of the bile ducts, and extrinsic compressions. The most common biliary cause of obstructive jaundice is the presence of stones. Intrinsic disorders of the bile ducts may be inflammatory, infectious, or neoplastic. And significant enlargement of adjacent lymph nodes due to metastatic tumors or lymphoma can occasionally obstruct the extrahepatic bile ducts. But obstructive jaundice produced by periportal tuberculous lymphadenitis with no evidence of pulmonary tuberculosis is very rare. We report a case of tuberculous lymphadenitis causing obstructive jaundice with a mass around mid common bile duct on abdominal sonogram, CT scan and ERCP, and it was confirmed by an exploratory laparotomy.
Bile Ducts
;
Bile Ducts, Extrahepatic
;
Cholangiopancreatography, Endoscopic Retrograde
;
Common Bile Duct
;
Jaundice, Obstructive*
;
Laparotomy
;
Lymph Nodes
;
Lymphoma
;
Tomography, X-Ray Computed
;
Tuberculosis, Lymph Node*
;
Tuberculosis, Pulmonary
10.Simultaneous duodenal and colon masses as late presentation of metastatic renal cell carcinoma.
Jung Gu LEE ; Jae Seon KIM ; Hyo Jung KIM ; Sung Tae KIM ; Jong Eun YEON ; Kwan Soo BYUN ; Jun Suk KIM ; Young Tae BAK ; Chang Hong LEE
The Korean Journal of Internal Medicine 2002;17(2):143-146
We report a case of pathologically proven simultaneous duodenal and colonic metastases about four years after nephrectomy for mixed clear and granular cell type renal cell carcinoma (RCC). A 76-year-old female patient who had undergone a left radical nephrectomy 4 years previously for RCC presented with a 1-month history of dyspepsia and pain in the right upper abdomen. An abdominopelvic CT scan showed circumferential wall thickening with high enhancement at the second portion of the duodenum and additional enhancement of an irregular protruding mass into the lumen of the ascending colon. A gastroscopy showed a large and ulcerative protruding mass nearly obstructing the second portion of the duodenum. A colonoscopy revealed a polypoid, nodular and purplish mass in the ascending colon. Microscopy of the biopsy specimen showed the features identical to those of the RCC which was resected 4 years earlier in this patient. We believe this to be the first case illustrating a metastatic renal cell carcinoma as simultaneous duodenal and colon masses.
Aged
;
Carcinoma, Renal Cell/pathology/*secondary
;
Case Report
;
Colonic Neoplasms/pathology/*secondary
;
Duodenal Neoplasms/pathology/*secondary
;
Female
;
Human
;
Kidney Neoplasms
;
Time Factors